MiNK Therapeutics, Inc.
INKT
$10.72
$0.212.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.64% | -59.84% | -56.85% | 27.45% | 54.88% |
| Total Depreciation and Amortization | -28.39% | -30.19% | 8.20% | -5.58% | 0.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.08% | 170.67% | 225.89% | 31.43% | -36.19% |
| Change in Net Operating Assets | 2,293.46% | 1,868.33% | 1,566.46% | -4.80% | -101.69% |
| Cash from Operations | -20.03% | 68.57% | 31.50% | 47.25% | 43.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 199,101.47% | -99.99% | -91.30% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 199,101.47% | -99.99% | -99.99% | -- |
| Foreign Exchange rate Adjustments | 5.53% | -285.19% | 182.63% | 87.84% | -646.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.41% | 522.03% | -144.41% | -154.78% | 42.24% |